Annie Mitsak

Bio:

Annie is an experienced investment professional with thirteen years of academic licensing and venture investing experience. Prior to joining Cure, Annie spent over six years on the investment team at Omega Funds, where she sourced, diligenced and led investments in companies within oncology, immunology, and rare diseases. Her broad investment experience ranges from company creation and academic spinouts to public company investments.

Prior to Omega Funds, Annie was an Associate Licensing Officer at MIT’s Technology Licensing Office where she worked closely with academic researchers within the Koch Institute for Integrative Cancer Research to manage patent portfolios and negotiate license agreements. Annie earned a Ph.D. in Biomedical Engineering from the University of Michigan and a B.S. in Biomedical Engineering from the University of Virginia, where she graduated with high honors and was a member of the Tau Beta Pi Honor Society.